Selected research
Market Outlook & Growth Opportunities
Global Single Molecule Real Time Sequencing Market Outlook and Growth Opportunities 2026
Market perspective
The global Single Molecule Real Time Sequencing market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Single Molecule Real Time Sequencing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Single Molecule Real Time Sequencing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Single Molecule Real Time Sequencing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Single Molecule Real Time Sequencing market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Single Molecule Real Time Sequencing market include Pacific Biosciences, Oxford Nanopore Technologies Limited, MicrobesNG, Creative Biomart, BGI, GENEWIZ, Novogene and Macrogen, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global Single Molecule Real Time Sequencing market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Single Molecule Real Time Sequencing and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Single Molecule Real Time Sequencing revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Single Molecule Real Time Sequencing market.
Single Molecule Real Time Sequencing Segment by Company
Pacific Biosciences
Oxford Nanopore Technologies Limited
MicrobesNG
Creative Biomart
BGI
GENEWIZ
Novogene
Macrogen
Single Molecule Real Time Sequencing Segment by Type
Pre-sequencing
Sequencing
Data Analysis
Single Molecule Real Time Sequencing Segment by Application
Academic & Research Institutes
Hospitals & Clinics
Pharmaceutical & Biotechnology Companies
Others
Single Molecule Real Time Sequencing Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Single Molecule Real Time Sequencing status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Single Molecule Real Time Sequencing key companies, revenue, market share, and recent developments.
3. To split the Single Molecule Real Time Sequencing breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Single Molecule Real Time Sequencing market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Single Molecule Real Time Sequencing significant trends, drivers, influence factors in global and regions.
6. To analyze Single Molecule Real Time Sequencing competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Single Molecule Real Time Sequencing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Single Molecule Real Time Sequencing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Single Molecule Real Time Sequencing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Single Molecule Real Time Sequencing industry.
Chapter 3: Detailed analysis of Single Molecule Real Time Sequencing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Single Molecule Real Time Sequencing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Single Molecule Real Time Sequencing in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Pre-sequencing
- Sequencing
- Data Analysis
Applications
- Academic & Research Institutes
- Hospitals & Clinics
- Pharmaceutical & Biotechnology Companies
- Others
Companies covered
- Pacific Biosciences
- Oxford Nanopore Technologies Limited
- MicrobesNG
- Creative Biomart
- BGI
- GENEWIZ
- Novogene
- Macrogen
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Single Molecule Real Time Sequencing Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Single Molecule Real Time Sequencing Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Single Molecule Real Time Sequencing Market Dynamics
- 2.1 Single Molecule Real Time Sequencing Industry Trends
- 2.2 Single Molecule Real Time Sequencing Industry Drivers
- 2.3 Single Molecule Real Time Sequencing Industry Opportunities and Challenges
- 2.4 Single Molecule Real Time Sequencing Industry Restraints
3 Single Molecule Real Time Sequencing Market by Company
- 3.1 Global Single Molecule Real Time Sequencing Company Revenue Ranking in 2025
- 3.2 Global Single Molecule Real Time Sequencing Revenue by Company (2021-2026)
- 3.3 Global Single Molecule Real Time Sequencing Company Ranking (2024-2026)
- 3.4 Global Single Molecule Real Time Sequencing Company Manufacturing Base and Headquarters
- 3.5 Global Single Molecule Real Time Sequencing Company Product Type and Application
- 3.6 Global Single Molecule Real Time Sequencing Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Single Molecule Real Time Sequencing Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Single Molecule Real Time Sequencing Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Single Molecule Real Time Sequencing Market by Type
- 4.1 Single Molecule Real Time Sequencing Type Introduction
- 4.1.1 Pre-sequencing
- 4.1.2 Sequencing
- 4.1.3 Data Analysis
- 4.2 Global Single Molecule Real Time Sequencing Sales Value by Type
- 4.2.1 Global Single Molecule Real Time Sequencing Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Single Molecule Real Time Sequencing Sales Value by Type (2021-2032)
- 4.2.3 Global Single Molecule Real Time Sequencing Sales Value Share by Type (2021-2032)
5 Single Molecule Real Time Sequencing Market by Application
- 5.1 Single Molecule Real Time Sequencing Application Introduction
- 5.1.1 Academic & Research Institutes
- 5.1.2 Hospitals & Clinics
- 5.1.3 Pharmaceutical & Biotechnology Companies
- 5.1.4 Others
- 5.2 Global Single Molecule Real Time Sequencing Sales Value by Application
- 5.2.1 Global Single Molecule Real Time Sequencing Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Single Molecule Real Time Sequencing Sales Value by Application (2021-2032)
- 5.2.3 Global Single Molecule Real Time Sequencing Sales Value Share by Application (2021-2032)
6 Single Molecule Real Time Sequencing Regional Value Analysis
- 6.1 Global Single Molecule Real Time Sequencing Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Single Molecule Real Time Sequencing Sales Value by Region (2021-2032)
- 6.2.1 Global Single Molecule Real Time Sequencing Sales Value by Region: 2021-2026
- 6.2.2 Global Single Molecule Real Time Sequencing Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Single Molecule Real Time Sequencing Sales Value (2021-2032)
- 6.3.2 North America Single Molecule Real Time Sequencing Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Single Molecule Real Time Sequencing Sales Value (2021-2032)
- 6.4.2 Europe Single Molecule Real Time Sequencing Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Single Molecule Real Time Sequencing Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Single Molecule Real Time Sequencing Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Single Molecule Real Time Sequencing Sales Value (2021-2032)
- 6.6.2 South America Single Molecule Real Time Sequencing Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Single Molecule Real Time Sequencing Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Single Molecule Real Time Sequencing Sales Value Share by Country, 2025 VS 2032
7 Single Molecule Real Time Sequencing Country-level Value Analysis
- 7.1 Global Single Molecule Real Time Sequencing Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Single Molecule Real Time Sequencing Sales Value by Country (2021-2032)
- 7.2.1 Global Single Molecule Real Time Sequencing Sales Value by Country (2021-2026)
- 7.2.2 Global Single Molecule Real Time Sequencing Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Single Molecule Real Time Sequencing Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Single Molecule Real Time Sequencing Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Single Molecule Real Time Sequencing Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Single Molecule Real Time Sequencing Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Single Molecule Real Time Sequencing Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Single Molecule Real Time Sequencing Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Single Molecule Real Time Sequencing Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Single Molecule Real Time Sequencing Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Single Molecule Real Time Sequencing Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Single Molecule Real Time Sequencing Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Single Molecule Real Time Sequencing Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Single Molecule Real Time Sequencing Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Single Molecule Real Time Sequencing Sales Value Growth Rate (2021-2032)
- 7.7.2 France Single Molecule Real Time Sequencing Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Single Molecule Real Time Sequencing Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Single Molecule Real Time Sequencing Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Single Molecule Real Time Sequencing Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Single Molecule Real Time Sequencing Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Single Molecule Real Time Sequencing Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Single Molecule Real Time Sequencing Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Single Molecule Real Time Sequencing Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Single Molecule Real Time Sequencing Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Single Molecule Real Time Sequencing Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Single Molecule Real Time Sequencing Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Single Molecule Real Time Sequencing Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Single Molecule Real Time Sequencing Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Single Molecule Real Time Sequencing Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Single Molecule Real Time Sequencing Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Single Molecule Real Time Sequencing Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Single Molecule Real Time Sequencing Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Single Molecule Real Time Sequencing Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Single Molecule Real Time Sequencing Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Single Molecule Real Time Sequencing Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Single Molecule Real Time Sequencing Sales Value Growth Rate (2021-2032)
- 7.14.2 China Single Molecule Real Time Sequencing Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Single Molecule Real Time Sequencing Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Single Molecule Real Time Sequencing Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Single Molecule Real Time Sequencing Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Single Molecule Real Time Sequencing Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Single Molecule Real Time Sequencing Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Single Molecule Real Time Sequencing Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Single Molecule Real Time Sequencing Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Single Molecule Real Time Sequencing Sales Value Growth Rate (2021-2032)
- 7.17.2 India Single Molecule Real Time Sequencing Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Single Molecule Real Time Sequencing Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Single Molecule Real Time Sequencing Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Single Molecule Real Time Sequencing Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Single Molecule Real Time Sequencing Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Single Molecule Real Time Sequencing Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Single Molecule Real Time Sequencing Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Single Molecule Real Time Sequencing Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Single Molecule Real Time Sequencing Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Single Molecule Real Time Sequencing Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Single Molecule Real Time Sequencing Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Single Molecule Real Time Sequencing Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Single Molecule Real Time Sequencing Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Single Molecule Real Time Sequencing Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Single Molecule Real Time Sequencing Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Single Molecule Real Time Sequencing Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Single Molecule Real Time Sequencing Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Single Molecule Real Time Sequencing Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Single Molecule Real Time Sequencing Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Single Molecule Real Time Sequencing Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Single Molecule Real Time Sequencing Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Single Molecule Real Time Sequencing Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Single Molecule Real Time Sequencing Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Single Molecule Real Time Sequencing Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Single Molecule Real Time Sequencing Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Single Molecule Real Time Sequencing Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Single Molecule Real Time Sequencing Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Single Molecule Real Time Sequencing Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Single Molecule Real Time Sequencing Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Single Molecule Real Time Sequencing Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Single Molecule Real Time Sequencing Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Single Molecule Real Time Sequencing Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Single Molecule Real Time Sequencing Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Single Molecule Real Time Sequencing Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Single Molecule Real Time Sequencing Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Single Molecule Real Time Sequencing Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Single Molecule Real Time Sequencing Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Single Molecule Real Time Sequencing Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Single Molecule Real Time Sequencing Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Single Molecule Real Time Sequencing Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Single Molecule Real Time Sequencing Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Pacific Biosciences
- 8.1.1 Pacific Biosciences Company Information
- 8.1.2 Pacific Biosciences Business Overview
- 8.1.3 Pacific Biosciences Single Molecule Real Time Sequencing Revenue and Gross Margin (2021-2026)
- 8.1.4 Pacific Biosciences Single Molecule Real Time Sequencing Product Portfolio
- 8.1.5 Pacific Biosciences Recent Developments
- 8.2 Oxford Nanopore Technologies Limited
- 8.2.1 Oxford Nanopore Technologies Limited Company Information
- 8.2.2 Oxford Nanopore Technologies Limited Business Overview
- 8.2.3 Oxford Nanopore Technologies Limited Single Molecule Real Time Sequencing Revenue and Gross Margin (2021-2026)
- 8.2.4 Oxford Nanopore Technologies Limited Single Molecule Real Time Sequencing Product Portfolio
- 8.2.5 Oxford Nanopore Technologies Limited Recent Developments
- 8.3 MicrobesNG
- 8.3.1 MicrobesNG Company Information
- 8.3.2 MicrobesNG Business Overview
- 8.3.3 MicrobesNG Single Molecule Real Time Sequencing Revenue and Gross Margin (2021-2026)
- 8.3.4 MicrobesNG Single Molecule Real Time Sequencing Product Portfolio
- 8.3.5 MicrobesNG Recent Developments
- 8.4 Creative Biomart
- 8.4.1 Creative Biomart Company Information
- 8.4.2 Creative Biomart Business Overview
- 8.4.3 Creative Biomart Single Molecule Real Time Sequencing Revenue and Gross Margin (2021-2026)
- 8.4.4 Creative Biomart Single Molecule Real Time Sequencing Product Portfolio
- 8.4.5 Creative Biomart Recent Developments
- 8.5 BGI
- 8.5.1 BGI Company Information
- 8.5.2 BGI Business Overview
- 8.5.3 BGI Single Molecule Real Time Sequencing Revenue and Gross Margin (2021-2026)
- 8.5.4 BGI Single Molecule Real Time Sequencing Product Portfolio
- 8.5.5 BGI Recent Developments
- 8.6 GENEWIZ
- 8.6.1 GENEWIZ Company Information
- 8.6.2 GENEWIZ Business Overview
- 8.6.3 GENEWIZ Single Molecule Real Time Sequencing Revenue and Gross Margin (2021-2026)
- 8.6.4 GENEWIZ Single Molecule Real Time Sequencing Product Portfolio
- 8.6.5 GENEWIZ Recent Developments
- 8.7 Novogene
- 8.7.1 Novogene Company Information
- 8.7.2 Novogene Business Overview
- 8.7.3 Novogene Single Molecule Real Time Sequencing Revenue and Gross Margin (2021-2026)
- 8.7.4 Novogene Single Molecule Real Time Sequencing Product Portfolio
- 8.7.5 Novogene Recent Developments
- 8.8 Macrogen
- 8.8.1 Macrogen Company Information
- 8.8.2 Macrogen Business Overview
- 8.8.3 Macrogen Single Molecule Real Time Sequencing Revenue and Gross Margin (2021-2026)
- 8.8.4 Macrogen Single Molecule Real Time Sequencing Product Portfolio
- 8.8.5 Macrogen Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst